Clinical Trial Update: Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of ruxolitinib phosphate and danazol to treat anemia in patients with primary or secondary myelofibrosis; results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Myelofibrosis

Drugs mentioned

• Danazol (danazol)
• Ruxolitinib phosphate (ruxolitinib phosphate)

Snippet

Sponsor: Mayo Clinic | Conditions: Anemia, Primary Myelofibrosis | Phase 2 | Status: COMPLETED | Results posted: 2017-10-18